← Back to headlines



NAFDAC Regulatory Reforms Drive Growth in Nigerian Pharmaceutical Sector
Nigeria's food and drug regulator reports that recent policy changes, including the ML3 status and 5+5 Policy, are significantly increasing domestic pharmaceutical manufacturing and drawing foreign investment.
2 Sept, 22:17 — 2 Sept, 22:17
Related Stories
Japan and U.S. Advance $550 Billion Investment Pact Focused on AI and Chips
1h ago

Anthropic Delays AI Startup IPO to Mid-October Amid Credit Facility Deal
2h ago

Trade Negotiations Stall as U.S. Halts Antitrust Cooperation With Canada
2h ago

Corporate Executives Across Various Sectors Sell Company Stock
2h ago